Report Detail

Request for Sample of this report

Pharma & Healthcare Global Latisse (Bimatoprost) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4616256
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.
According to our (Global Info Research) latest study, the global Latisse (Bimatoprost) market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
Global Latisse (Bimatoprost) (CAS 155206-00-1) key players include Chirogate International, Cayman Pharma, Zhejiang Ausun, Everlight Chemical, and Lianmin Biochemical etc. Global top three players hold a share about 40%. North America is the largest market, with a share about 90%.
This report is a detailed and comprehensive analysis for global Latisse (Bimatoprost) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Latisse (Bimatoprost) market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2019-2030
Global Latisse (Bimatoprost) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2019-2030
Global Latisse (Bimatoprost) market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2019-2030
Global Latisse (Bimatoprost) market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (US$/g), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Latisse (Bimatoprost)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Latisse (Bimatoprost) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cayman Pharma, Tecoland Corporation, TCS Group, Changzhou BOHIV, Zhejiang Ausun, Ansion Pharma, Lianmin Biochemical, Chirogate International, Everlight Chemical, GENTEC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Latisse (Bimatoprost) market is split by Purity and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity
Below 99.5%
Other
Market segment by Application
Patented Product
General Products
Major players covered
Cayman Pharma
Tecoland Corporation
TCS Group
Changzhou BOHIV
Zhejiang Ausun
Ansion Pharma
Lianmin Biochemical
Chirogate International
Everlight Chemical
GENTEC
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Latisse (Bimatoprost) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Latisse (Bimatoprost), with price, sales quantity, revenue, and global market share of Latisse (Bimatoprost) from 2019 to 2024.
Chapter 3, the Latisse (Bimatoprost) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Latisse (Bimatoprost) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Latisse (Bimatoprost) market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Latisse (Bimatoprost).
Chapter 14 and 15, to describe Latisse (Bimatoprost) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Purity
    • 1.3.1 Overview: Global Latisse (Bimatoprost) Consumption Value by Purity: 2019 Versus 2023 Versus 2030
    • 1.3.2 Below 99.5%
    • 1.3.3 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Latisse (Bimatoprost) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Patented Product
    • 1.4.3 General Products
  • 1.5 Global Latisse (Bimatoprost) Market Size & Forecast
    • 1.5.1 Global Latisse (Bimatoprost) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Latisse (Bimatoprost) Sales Quantity (2019-2030)
    • 1.5.3 Global Latisse (Bimatoprost) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Cayman Pharma
    • 2.1.1 Cayman Pharma Details
    • 2.1.2 Cayman Pharma Major Business
    • 2.1.3 Cayman Pharma Latisse (Bimatoprost) Product and Services
    • 2.1.4 Cayman Pharma Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cayman Pharma Recent Developments/Updates
  • 2.2 Tecoland Corporation
    • 2.2.1 Tecoland Corporation Details
    • 2.2.2 Tecoland Corporation Major Business
    • 2.2.3 Tecoland Corporation Latisse (Bimatoprost) Product and Services
    • 2.2.4 Tecoland Corporation Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Tecoland Corporation Recent Developments/Updates
  • 2.3 TCS Group
    • 2.3.1 TCS Group Details
    • 2.3.2 TCS Group Major Business
    • 2.3.3 TCS Group Latisse (Bimatoprost) Product and Services
    • 2.3.4 TCS Group Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 TCS Group Recent Developments/Updates
  • 2.4 Changzhou BOHIV
    • 2.4.1 Changzhou BOHIV Details
    • 2.4.2 Changzhou BOHIV Major Business
    • 2.4.3 Changzhou BOHIV Latisse (Bimatoprost) Product and Services
    • 2.4.4 Changzhou BOHIV Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Changzhou BOHIV Recent Developments/Updates
  • 2.5 Zhejiang Ausun
    • 2.5.1 Zhejiang Ausun Details
    • 2.5.2 Zhejiang Ausun Major Business
    • 2.5.3 Zhejiang Ausun Latisse (Bimatoprost) Product and Services
    • 2.5.4 Zhejiang Ausun Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Zhejiang Ausun Recent Developments/Updates
  • 2.6 Ansion Pharma
    • 2.6.1 Ansion Pharma Details
    • 2.6.2 Ansion Pharma Major Business
    • 2.6.3 Ansion Pharma Latisse (Bimatoprost) Product and Services
    • 2.6.4 Ansion Pharma Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Ansion Pharma Recent Developments/Updates
  • 2.7 Lianmin Biochemical
    • 2.7.1 Lianmin Biochemical Details
    • 2.7.2 Lianmin Biochemical Major Business
    • 2.7.3 Lianmin Biochemical Latisse (Bimatoprost) Product and Services
    • 2.7.4 Lianmin Biochemical Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Lianmin Biochemical Recent Developments/Updates
  • 2.8 Chirogate International
    • 2.8.1 Chirogate International Details
    • 2.8.2 Chirogate International Major Business
    • 2.8.3 Chirogate International Latisse (Bimatoprost) Product and Services
    • 2.8.4 Chirogate International Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Chirogate International Recent Developments/Updates
  • 2.9 Everlight Chemical
    • 2.9.1 Everlight Chemical Details
    • 2.9.2 Everlight Chemical Major Business
    • 2.9.3 Everlight Chemical Latisse (Bimatoprost) Product and Services
    • 2.9.4 Everlight Chemical Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Everlight Chemical Recent Developments/Updates
  • 2.10 GENTEC
    • 2.10.1 GENTEC Details
    • 2.10.2 GENTEC Major Business
    • 2.10.3 GENTEC Latisse (Bimatoprost) Product and Services
    • 2.10.4 GENTEC Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 GENTEC Recent Developments/Updates

3 Competitive Environment: Latisse (Bimatoprost) by Manufacturer

  • 3.1 Global Latisse (Bimatoprost) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Latisse (Bimatoprost) Revenue by Manufacturer (2019-2024)
  • 3.3 Global Latisse (Bimatoprost) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Latisse (Bimatoprost) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Latisse (Bimatoprost) Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Latisse (Bimatoprost) Manufacturer Market Share in 2023
  • 3.5 Latisse (Bimatoprost) Market: Overall Company Footprint Analysis
    • 3.5.1 Latisse (Bimatoprost) Market: Region Footprint
    • 3.5.2 Latisse (Bimatoprost) Market: Company Product Type Footprint
    • 3.5.3 Latisse (Bimatoprost) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Latisse (Bimatoprost) Market Size by Region
    • 4.1.1 Global Latisse (Bimatoprost) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Latisse (Bimatoprost) Consumption Value by Region (2019-2030)
    • 4.1.3 Global Latisse (Bimatoprost) Average Price by Region (2019-2030)
  • 4.2 North America Latisse (Bimatoprost) Consumption Value (2019-2030)
  • 4.3 Europe Latisse (Bimatoprost) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Latisse (Bimatoprost) Consumption Value (2019-2030)
  • 4.5 South America Latisse (Bimatoprost) Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Latisse (Bimatoprost) Consumption Value (2019-2030)

5 Market Segment by Purity

  • 5.1 Global Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 5.2 Global Latisse (Bimatoprost) Consumption Value by Purity (2019-2030)
  • 5.3 Global Latisse (Bimatoprost) Average Price by Purity (2019-2030)

6 Market Segment by Application

  • 6.1 Global Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 6.2 Global Latisse (Bimatoprost) Consumption Value by Application (2019-2030)
  • 6.3 Global Latisse (Bimatoprost) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 7.2 North America Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 7.3 North America Latisse (Bimatoprost) Market Size by Country
    • 7.3.1 North America Latisse (Bimatoprost) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Latisse (Bimatoprost) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 8.2 Europe Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 8.3 Europe Latisse (Bimatoprost) Market Size by Country
    • 8.3.1 Europe Latisse (Bimatoprost) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Latisse (Bimatoprost) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 9.2 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Latisse (Bimatoprost) Market Size by Region
    • 9.3.1 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Latisse (Bimatoprost) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 10.2 South America Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 10.3 South America Latisse (Bimatoprost) Market Size by Country
    • 10.3.1 South America Latisse (Bimatoprost) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Latisse (Bimatoprost) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Purity (2019-2030)
  • 11.2 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Latisse (Bimatoprost) Market Size by Country
    • 11.3.1 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Latisse (Bimatoprost) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Latisse (Bimatoprost) Market Drivers
  • 12.2 Latisse (Bimatoprost) Market Restraints
  • 12.3 Latisse (Bimatoprost) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Latisse (Bimatoprost) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Latisse (Bimatoprost)
  • 13.3 Latisse (Bimatoprost) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Latisse (Bimatoprost) Typical Distributors
  • 14.3 Latisse (Bimatoprost) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Latisse (Bimatoprost). Industry analysis & Market Report on Latisse (Bimatoprost) is a syndicated market report, published as Global Latisse (Bimatoprost) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Latisse (Bimatoprost) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,634.36
    		3,951.54
    		5,268.72
    		3,132.00
    		4,698.00
    		6,264.00
    		494,682.00
    		742,023.00
    		989,364.00
    		291,380.40
    		437,070.60
    		582,760.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo